Ep 109: Recovery Therapies for Mold Related Illness w/ Michelle McKeon

Home » Ep 109: Recovery Therapies for Mold Related Illness w/ Michelle McKeon

Written by Michelle McKeon

May 19, 2022

Listen to this episode: https://player.fm/series/moldfinders-radio/ep-109-recovery-therapies-for-mold-related-illness-wmichelle-mckeon

This was such a great talk! Here is an overview… Mold Related Illness treatments can be similar because they address root inflammation issues. Step 1: Open inflammation pathways Step 2: Detox phases Step 3: Binders Do you have Lyme? Here is Michelle’s recommended order of treatment. Step 1: Begin treating for mold Step 2: Get out of / fix your moldy environment Step 3: Treat Lyme How to think about your contents and belonging and what to do about them. A breakdown on hyperthermia treatment. Enjoy!

Related Articles & Podcasts

CDC Validates Chronic Lyme Disease

CDC Validates Chronic Lyme Disease

Recently the CDC added a new page titled, “Chronic Symptoms Following Infections”.  This page acknowledges Chronic Lyme Disease for the first time on the CDC website. It states that “Infections can sometimes leave people with symptoms that last for weeks to months or...

Ep 376: My Lyme Doc – An Interview With Doctor Diane Mueller

Ep 376: My Lyme Doc – An Interview With Doctor Diane Mueller

In this episode of our Tick Boot Camp Podcast, we welcome back Dr. Diane Mueller, a leading voice in Lyme disease treatment, and co-host Michelle McKeon, a specialist in tick-borne infections and environmental toxins. Listen to this episode:...

Lyme Disease Vaccine: The Past, Present, and Future

Lyme Disease Vaccine: The Past, Present, and Future

Lyme disease, caused by the bacteria Borrelia burgdorferi and transmitted through ticks, has become a prominent concern in many parts of the world. According to the CDC, an estimated 500,000 people are infected with Lyme each year,1  and as the prevalence...

Stay Up to Date With The Latest News & Updates

Free Discovery Call

Get the latest info

Sign Up For Our Newsletter

Consent
This field is for validation purposes and should be left unchanged.